NextPhase Research Alliance at CANO HEALTH (Site 107) — Miami, Florida

NextPhase Research Alliance at CANO HEALTH (Site 107) is a clinical research site located in Miami, Florida, United States 33144.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

NextPhase Research Alliance at CANO HEALTH (Site 107) has participated in 1 clinical trials.

Therapeutic areas: COVID-19.

Sponsors: Sagent Pharmaceuticals Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NextPhase Research Alliance at CANO HEALTH (Site 107)?

NextPhase Research Alliance at CANO HEALTH (Site 107) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NextPhase Research Alliance at CANO HEALTH (Site 107) conducted?

NextPhase Research Alliance at CANO HEALTH (Site 107) has 1 clinical trials on record. Their work covers COVID-19.

Is NextPhase Research Alliance at CANO HEALTH (Site 107) accredited by Crixeo Health?

NextPhase Research Alliance at CANO HEALTH (Site 107) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NextPhase Research Alliance at CANO HEALTH (Site 107)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.